【レポートの概要（一部）】
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Molecule Type
08. Geographical Segmentation
09. Buying Criteria
10. Global Protein Therapeutics Market
10.1 Introduction
10.2 Drivers, Challenges and Trends
10.3 Market Size and Forecast
10.4 Market Segmentation by Molecule Type
10.4.1 Global Monoclonal Antibodies Market
10.4.2 Global Enzymes Market
10.4.3 Global Other Protein Therapeutics Market
11. Global Vaccines Market
11.1 Introduction
11.2 Drivers, Challenges and Trends
11.3 Market Size and Forecast
11.4 Market Segmentation by Composition
11.5 Market Segmentation by End-user Age Group
11.5.1 Global Pediatric Vaccines Market
11.5.2 Global Adult Vaccines Market
12. Global Cell Therapy Market
12.1 Introduction
12.2 Drivers, Challenges and Trends
12.3 Market Size and Forecast
13. Market Growth Drivers
13.1.1 Overall Market Drivers
13.1.2 Segment Specific Drivers
14. Drivers and their Impact
15. Market Challenges
15.1.1 Overall Market Challenges
15.1.2 Segment Specific Challenges
16. Impact of Drivers and Challenges
17. Market Trends
17.1.1 Overall Market Trends
17.1.2 Segment Specific Trends
18. Trends and their Impact
19. Competitive Scenario
19.1 Key News
19.2 Mergers and Acquisitions
20. Market Share Analysis 2013
20.1 Market Snapshot of Top Vendors
20.2 Market Share of Key Vendors
20.3 Market Forecast of Key Vendors
20.3.1 F. Hoffmann-La Roche
20.3.2 Sanofi
20.3.3 Amgen
20.3.4 Novo Nordisk
21. Market Assessment of Major Biologic Therapeutics of Key Vendors
21.1 F. Hoffmann-La Roche
21.1.1 Avastin
21.1.2 Herceptin
21.1.3 Kadcyla
21.1.4 Lucentis
21.1.5 MabThera/Rituxan
21.1.6 Pegasys
21.1.7 Perjeta
21.2 Sanofi
21.2.1 Aldurazyme
21.2.2 Cerezyme
21.2.3 Fabrazyme
21.2.4 Myozyme/Lumizyme
21.2.5 Lantus
21.3 Amgen
21.3.1 Enbrel
21.3.2 Neulasta
21.3.3 Xgeva/Prolia
21.4 Novo Nordisk
21.4.1 NovoRapid/NovoLog
21.4.2 Victoza
21.5 Other Prominent and Future Vendors
22. Key Vendor Analysis
22.1 Amgen
22.1.1 Key Facts
22.1.2 Business Overview
22.1.3 Product Segmentation by Revenue 2013
22.1.4 Sales by Geographical Segmentation 2013
22.1.5 Business Strategy
22.1.6 Key Information
22.1.7 SWOT Analysis
22.2 F. Hoffmann-La Roche
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Segmentation
22.2.4 Business Segmentation by Revenue 2012 and 2013
22.2.5 Geographical Segmentation by Revenue
22.2.6 Business Strategy
22.2.7 Key Information
22.2.8 SWOT Analysis
22.3 Novo Nordisk A/S
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Segmentation
22.3.4 Business Strategy
22.3.5 Revenue Segmentation by Business
22.3.6 Revenue Comparison by Business Segments 2012 and 2013
22.3.7 Sales by Geography
22.3.8 Key Information
22.3.9 SWOT Analysis
22.4 Sanofi
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Business Segmentation by Revenue 2013
22.4.4 Business Segmentation by Revenue 2012 and 2013
22.4.5 Geographical Segmentation by Revenue 2013
22.4.6 Business Strategy
22.4.7 Key Developments
22.4.8 SWOT Analysis
23. Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Global Biologic Therapeutics Market 2013-2018 (US$ billion)
Exhibit 3: Global Biologic Therapeutics Market Segmentation by Molecule Type
Exhibit 4: Global Biologic Therapeutics Market by Molecule Type 2013
Exhibit 5: Global Biologic Therapeutics Market by Molecule Type 2018
Exhibit 6: Global Biologic Therapeutics Market by Molecule Type 2013-2018 (US$ billion)
Exhibit 7: Global Biologic Therapeutics Market by Molecule Type 2013-2018
Exhibit 8: Global Biologic Therapeutics Market Segments 2013-2018
Exhibit 9: YoY Growth Rate of Global Biologic Therapeutics Market Segments 2013-2018
Exhibit 10: Global Biologic Therapeutics Market Segmentation by Geography 2013
Exhibit 11: Key Factors Influencing the Global Protein Therapeutics Market
Exhibit 12: Global Protein Therapeutics Market Key Trends
Exhibit 13: Global Protein Therapeutics Market 2013-2018 (US$ billion)
Exhibit 14: Global Protein Therapeutics Market by Molecule Type
Exhibit 15: Global Protein Therapeutics Market by Molecule Type 2013
Exhibit 16: Global Protein Therapeutics Market by Molecule Type 2018
Exhibit 17: Global Protein Therapeutics Market by Molecule Type 2013-2018 (US$ billion)
Exhibit 18: Global Protein Therapeutics Market by Molecule Type 2013-2018
Exhibit 19: Global Protein Therapeutics Market Segmentation 2013-2018
Exhibit 20: YoY Growth Rate of Global Protein Therapeutics Market Segments 2013-2018
Exhibit 21: Global Monoclonal Antibodies Market 2013-2018 (US$ billion)
Exhibit 22: Global Enzymes Market 2013-2018 (US$ billion)
Exhibit 23: Global Other Protein Therapeutics Market 2013-2018 (US$ billion)
Exhibit 24: Global Vaccines Market Drivers
Exhibit 25: Global Vaccines Market Challenges
Exhibit 26: Global Vaccines Market Trends
Exhibit 27: Global Vaccines Market 2013-2018 (US$ billion)
Exhibit 28: Global Vaccines Market Segmentation by Vaccine Type
Exhibit 29: Global Vaccines Market Segmentation by End-user Age Group
Exhibit 30: Global Vaccines Market Segmentation by End-user Age Group 2013
Exhibit 31: Global Vaccines Market Segmentation by End-user Age Group 2018
Exhibit 32: Global Vaccines Market Segmentation by End-user Age Group 2013-2018 (US$ billion)
Exhibit 33: Global Vaccines Market Segmentation by End-user Age Group 2013-2018
Exhibit 34: Global Vaccines Market Segmentation 2013-2018
Exhibit 35: YoY Growth Rate of Global Vaccines Market Segments 2013-2018
Exhibit 36: Global Pediatric Vaccines Market 2013-2018 (US$ billion)
Exhibit 37: Global Adult Vaccines Market 2013-2018 (US$ billion)
Exhibit 38: Key Factors Influencing the Global Cell Therapy Market
Exhibit 39: Global Cell Therapy Market 2013-2018 (US$ billion)
Exhibit 40: Global Biologic Therapeutics Market Drivers
Exhibit 41: Global Biologic Therapeutics Overall Market Drivers
Exhibit 42: World’s Population Aged 60 and Above 2010-2020 (billion)
Exhibit 43: Global Biologic Therapeutics Segment Specific Drivers
Exhibit 44: Incidence and Prevalence of Type 1 Diabetes in Children (0-14 Years) 2013 (in thousands)
Exhibit 45: Global Biologic Therapeutics Market Challenges
Exhibit 46: Global Biologic Therapeutics Overall Market Challenges
Exhibit 47: Global Biologic Therapeutics Segment Specific Challenges
Exhibit 48: Global Biologic Therapeutics Market Trends
Exhibit 49: Global Biologic Therapeutics Market General Trends
Exhibit 50: Global Biologic Therapeutics Segment Specific Trends
Exhibit 51: Market Statistics for Key Vendors in Global Biologic Therapeutics Market
Exhibit 52: Global Biologic Therapeutics Market Share Analysis 2013
Exhibit 53: Global Biologic Therapeutics Market Share Analysis 2018
Exhibit 54: Global Biologic Therapeutics Market Share Analysis of Key Vendors 2013
Exhibit 55: Global Biologic Therapeutics Market Share Analysis of Key Vendors 2018
Exhibit 56: YoY Growth Rate of Key Vendors in the Global Biologic Therapeutics Market
Exhibit 57: F. Hoffmann-La Roche Biologic Therapeutics Market Size and Forecast 2013-2018 (US$ billion)
Exhibit 58: Sanofi Biologic Therapeutics Market Size and Forecast 2013-2018 (US$ billion)
Exhibit 59: Amgen Biologic Therapeutics Market Size and Forecast 2013-2018 (US$ billion)
Exhibit 60: Novo Nordisk Biologic Therapeutics Market Size and Forecast 2013-2018 (US$ billion)
Exhibit 61: Revenue of Major Biologic Therapeutics of Key Vendors
Exhibit 62: F. Hoffmann-La Roche: Market Sales for Key Biologic Therapeutics 2013 (US$ million)
Exhibit 63: Geography-wise Segmentation of Avastin 2013 (US$ million)
Exhibit 64: Geography-wise Segmentation of Avastin 2013
Exhibit 65: Avastin Market Size and Forecast 2013-2018 (US$ million)
Exhibit 66: Geography-wise Segmentation of Herceptin 2013 (US$ million)
Exhibit 67: Geography-wise Segmentation of Herceptin 2013
Exhibit 68: Herceptin Market Size and Forecast 2013-2018 (US$ million)
Exhibit 69: Geography-wise Segmentation of Kadcyla 2013 (US$ million)
Exhibit 70: Geography-wise Segmentation of Kadcyla 2013
Exhibit 71: Kadcyla Market Size and Forecast 2013-2018 (US$ million)
Exhibit 72: Timeline of Key Regulatory Approvals of Lucentis
Exhibit 73: Lucentis Sales by Geographical Segmentation 2006-2013 (US$ million)
Exhibit 74: Lucentis Revenue 2006-2013 (US$ million)
Exhibit 75: Geography-wise Segmentation of MabThera/Rituxan 2013 (US$ million)
Exhibit 76: Geography-wise Segmentation of MabThera/Rituxan 2013
Exhibit 77: MabThera/Rituxan Market Size and Forecast 2013-2018 (US$ million)
Exhibit 78: Geography-wise Segmentation of Pegasys 2013 (US$ million)
Exhibit 79: Geography-wise Segmentation of Pegasys 2013
Exhibit 80: Geography-wise Segmentation of Perjeta 2013 (US$ million)
Exhibit 81: Geography-wise Segmentation of Perjeta 2013
Exhibit 82: Perjeta Market Size and Forecast 2013-2018 (US$ million)
Exhibit 83: SanofI: Market Sales for Key Biologic Therapeutics 2013 (US$ million)
Exhibit 84: Geography-wise Segmentation of Aldurazyme 2013 (US$ million)
Exhibit 85: Geography-wise Segmentation of Aldurazyme 2013
Exhibit 86: Geography-wise Segmentation of Cerezyme 2013 (US$ million)
Exhibit 87: Geography-wise Segmentation of Cerezyme 2013
Exhibit 88: Geography-wise Segmentation of Fabrazyme 2013 (US$ million)
Exhibit 89: Geography-wise Segmentation of Fabrazyme 2013
Exhibit 90: Geography-wise Segmentation of Myozyme/Lumizyme 2013 (US$ million)
Exhibit 91: Geography-wise Segmentation of Myozyme/Lumizyme 2013
Exhibit 92: Geography-wise Segmentation of Lantus 2013 (US$ million)
Exhibit 93: Geography-wise Segmentation of Lantus 2013
Exhibit 94: Lantus Market Size and Forecast 2013-2018 (US$ million)
Exhibit 95: Geography-wise Segmentation of Enbrel 2013 (US$ million)
Exhibit 96: Geography-wise Segmentation of Enbrel 2013
Exhibit 97: Enbrel Market Size and Forecast 2013-2018 (US$ million)
Exhibit 98: Geography-wise Segmentation of Neulasta 2013 (US$ million)
Exhibit 99: Geography-wise Segmentation of Neulasta 2013
Exhibit 100: Neulasta Market Size and Forecast 2013-2018 (US$ million)
Exhibit 101: Geography-wise Segmentation of Xgeva/Prolia 2013 (US$ million)
Exhibit 102: Geography-wise Segmentation of Xgeva/Prolia 2013
Exhibit 103: Xgeva/Prolia Market Size and Forecast 2013-2018 (US$ million)
Exhibit 104: Market Sales for Key Biologic Therapeutics 2013 (US$ million)
Exhibit 105: Geography-wise Sales for Key Biologic Therapeutics 2013 (US$ million)
Exhibit 106: Geography-wise Segmentation of NovoRapid/NovoLog 2013 (US$ million)
Exhibit 107: Geography-wise Segmentation of NovoRapid/NovoLog 2013
Exhibit 108: NovoRapid/NovoLog Market Size and Forecast 2013-2018 (US$ million)
Exhibit 109: Geography-wise Segmentation of Victoza 2013 (US$ million)
Exhibit 110: Geography-wise Segmentation of Victoza 2013
Exhibit 111: Victoza Market Size and Forecast 2013-2018 (US$ million)
Exhibit 112: Amgen: Product Segmentation by Revenue 2013
Exhibit 113: Amgen: Sales by Geographical Segmentation 2013
Exhibit 114: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 115: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 116: F. Hoffmann-La Roche: Revenue of Pharmaceuticals Division by Geography 2013
Exhibit 117: F. Hoffmann-La Roche: Revenue of Diagnostics Division by Geography 2013
Exhibit 118: Business Segments of Novo Nordisk A/S 2013
Exhibit 119: Novo Nordisk A/S: Business Segmentation 2013
Exhibit 120: Novo Nordisk A/S: Revenue Comparison 2012 and 2013 (US$ million)
Exhibit 121: Novo Nordisk A/S: Sales by Geography 2013
Exhibit 122: Sanofi: Business Segmentation by Revenue 2013
Exhibit 123: Sanofi: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 124: Sanofi: Geographical Segmentation by Revenue 2013
【レポート販売概要】
■ タイトル：生物学的製剤の世界市場：タンパク質治療薬、ワクチン、細胞治療薬■ 英文：Global Biologic Therapeutics Market 2014-2018
■ 発行日：2014年10月29日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4486
■ 調査対象地域：グローバル
- ネットワーク分析ソリューションの世界市場：無線通信、VoIP、固定通信、ユニファイド・コミュニケーションThe global network analytics market is estimated to grow at a CAGR of 25.6% from 2014 to 2019. Although the mature markets (such as the U.S. and the U.K.) hold larger shares in the network analytics market, the Asia-Pacific region is expected to grow at the highest CAGR of 32% during the forecast period. Growing network traffic, upgradation of technologies, Quality of Experience (QoE), maintenance …
- アクリル酸2エチルヘキシルの世界市場The global 2-ethylhexyl acrylate market is estimated to grow at a CAGR of 6.5% from 2014 to 2019. The Asia-Pacific region holds the largest share of the global 2-ethylhexyl acrylate market, having accounted for 38% of the global market in 2014. The Asia-Pacific market is projected to grow at a CAGR of 8.6% from 2014 to 2019. In this report, the global 2-ethylhexyl acrylate market has been broadly …
- 世界のアルコール飲料（酒類）市場：ビール、ワイン、スピリッツ、ウイスキー、白酒（中国）、ウォッカ、ラム酒などAbout Alcoholic Drinks Alcoholic drinks comprise beer, spirits, and wine. In 2013, the Beer segment led the market with 53.24 percent and 75.34 percent share, respectively, in terms of revenue and volume. An increase in the demand among millennial population in the US, growing demand for premium alcoholic beverages, and increased marketing and promotions by vendors drive the consumption and sales …
- 北米の手術室用装置市場見通し（～2021）North America Operating Room Equipment Market Outlook to 2021 Summary GlobalData’s new report, "North America Operating Room Equipment Market Outlook to 2021", provides key market data on the North America Operating Room Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Operating Room Tables, O …
- 世界における小型自動車用トランスミッション及びクラッチ市場（2008-2028）This latest just-auto report edition offers a global review of the OE transmissions sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE transmissions market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and pro …
- 韓国の注射器・注射針市場見通し（～2021）South Korea Syringes and Needles Market Outlook to 2021 Summary GlobalData’s new report, "South Korea Syringes and Needles Market Outlook to 2021", provides key market data on the South Korea Syringes and Needles market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - General Syringes and Specialized Syringes. …
- IoTの世界市場分析：コンポーネント別（デバイス、接続性、ITサービス、プラットフォーム）、用途別（消費者家電、小売、製造、輸送、ヘルスケア）、セグメント予測The Internet of Things (IoT) market was worth USD 605.69 billion in 2014 owing to rising requirement for internet connectivity worldwide coupled with technological advancements. The emergence of start-ups in different industries to satisfy growing need of consumers is anticipated to result in increasing venture capital investments. The market is estimated to grow at 15.2 % to reach over USD 1.88 t …
- 飽和ポリエステル樹脂（SPR）の世界市場：液状SPR、固形SPRThe global saturated polyester resin market is projected to reach USD 4.77 Billion by 2021, growing at a CAGR of 5.83% from 2016 to 2021. The key drivers of the market are environmental concerns, growing awareness, stringent regulations for VOC emissions, and high performance of saturated polyester resin owing to its superior mechanical properties. Solid saturated polyester resins are used for man …
- シランの世界市場2018-2022112 pages, November 2018 About this market The market has undergone rapid consolidation due to increased merger and acquisitions in the market. This has resulted in the presence of more competent and technology- driven players in the market. Therefore, the growing number of mergers and acquisitions is expected to further consolidate the global silanes market during the forecast market. The promine …
- 世界の平型柔軟ケーブル市場2015The Global Flexible Flat Cable Research Report 2015 is a professional and in-depth study on the current state of the Flexible Flat Cable industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Flexible Flat Cable market analysis is provided for the international markets including development trends, compe …
- 世界のリソソーム蓄積症治療/医薬品市場（2014-2018）About Lysosomal Storage Diseases The term lysosomal storage diseases refers to a group of rare inherited disorders caused by the deficiency of lysosomal enzymes, activator proteins, proteins required for normal post-translational modification of lysosomal enzymes or proteins required for intracellular transport between lysosome and other cellular compartments. These deficiencies result in deficien …
- 構造発泡体の世界市場：ポリエチレン、ポリプロピレン、ポリスチレン、ポリウレタンStructural foams are defined as thermoplastic products, which have a foamed cellular core with a solid skin surrounding the core. It is generally developed through a form of injection molding, by using molten plastic/polymer mixed with a chemical blowing agent or inert gas. Other processes such as reaction injection molding (RIM), high pressure expansion, and co-injection are also used for manufac …
- デオドラント（脱臭剤）の世界市場：スプレー式デオドラント、ロールオン式デオドラント、スティック・固形デオドラントAbout the Global Deodorant Market Deodorants and antiperspirants are in high demand in developed regions such as the Americas and Western Europe. With consumers there increasingly opting for products that contain natural ingredients, manufacturers have been reformulating their products to cater to this requirement. The growing implementation of daily grooming routines among teenagers and white col …
- 自動車シリンダーヘッドの世界市場2016-2020About Automotive Cylinder Head An automotive cylinder head is the end cover in an internal combustion engine. It is used against the piston, which compresses the cylinder's contents. In an internal combustion engine, the cylinder head sits above the cylinders on top of the cylinder block. It closes the top of the cylinder, which forms the combustion chamber. This joint is sealed by a head gasket. …
- 世界の電子メール暗号化市場動向（2014-2018）About Email Encryption Email encryption refers to the encryption of emails as a security measure to protect the content from unauthorized access. There are different protocols for email encryption such as PGP, S/MIME, TLS, identity-based encryption, and mail sessions encryption. These email encryption products are available either as software or as an appliance, such as a gateway device. In a poli …
